Literature DB >> 25036910

"High-risk stigmata" of the 2012 international consensus guidelines correlate with the malignant grade of branch duct intraductal papillary mucinous neoplasms of the pancreas.

Teppei Aso1, Takao Ohtsuka, Taketo Matsunaga, Hideyo Kimura, Yusuke Watanabe, Koji Tamura, Noboru Ideno, Takashi Osoegawa, Shunnichi Takahata, Koji Shindo, Yasuhiro Ushijima, Shinichi Aishima, Yoshinao Oda, Tetsuhide Ito, Kazuhiro Mizumoto, Masao Tanaka.   

Abstract

OBJECTIVES: The 2012 international consensus guidelines for the management of intraductal papillary mucinous neoplasm (IPMN) of the pancreas stratified patients into 2 clinical categories, "high-risk stigmata" and "worrisome features," and recommended different therapeutic strategies for these groups. The aim of this study was to elucidate the significance of these categories in terms of predicting malignant IPMNs.
METHODS: The medical records of 100 consecutive patients who underwent pancreatectomy for IPMNs were retrospectively reviewed. Seventy patients with branch duct IPMNs (BD-IPMNs) were stratified into 3 groups. The relationships between the number of predictive factors and histopathologic grade were investigated.
RESULTS: The prevalence rates of malignant IPMN, invasive carcinoma, and lymph node metastasis in the high-risk group were 80%, 55%, and 20%, respectively, with these percentages significantly increasing in a stepwise manner according to the number of predictive factors. In contrast, there was no significant correlation between the number of worrisome features and grade of malignancy in patients stratified as having worrisome BD-IPMNs.
CONCLUSIONS: The number of high-risk stigmata correlated significantly with the grade of malignancy of BD-IPMNs. The presence of at least 1 high-risk stigma in patients with BD-IPMNs indicates a need for pancreatectomy with lymphadenectomy.

Entities:  

Mesh:

Year:  2014        PMID: 25036910     DOI: 10.1097/MPA.0000000000000199

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  26 in total

1.  Comparison between MRI with MR cholangiopancreatography and endoscopic ultrasonography for differentiating malignant from benign mucinous neoplasms of the pancreas.

Authors:  Jiyoung Hwang; Young Kon Kim; Ji Hye Min; Woo Kyung Jeong; Seong Sook Hong; Hyun-Joo Kim
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

2.  Surgical outcomes of multifocal branch duct intraductal papillary mucinous neoplasms of pancreas.

Authors:  Jae Hyun Kwon; Song Cheol Kim; Ki-Byung Song; Jae Hoon Lee; Dae Wook Hwang; Kwang-Min Park; Young-Joo Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2014-11-30

3.  Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Authors:  Mohammad A Al Efishat; Marc A Attiyeh; Anne A Eaton; Mithat Gönen; Denise Prosser; Anna E Lokshin; Carlos Fernández-Del Castillo; Keith D Lillemoe; Cristina R Ferrone; Ilaria Pergolini; Mari Mino-Kenudson; Neda Rezaee; Marco Dal Molin; Matthew J Weiss; John L Cameron; Ralph H Hruban; Michael I D'Angelica; T Peter Kingham; Ronald P DeMatteo; William R Jarnagin; Christopher L Wolfgang; Peter J Allen
Journal:  Ann Surg       Date:  2018-08       Impact factor: 12.969

Review 4.  Diagnosis and management of pancreatic cystic neoplasms.

Authors:  Mathew James Keegan; Bharat Paranandi
Journal:  Frontline Gastroenterol       Date:  2019-03-01

Review 5.  Current best practice and controversies in the follow up of patients with asymptomatic branch duct IPMN of the pancreas.

Authors:  Masao Tanaka
Journal:  HPB (Oxford)       Date:  2016-07-21       Impact factor: 3.647

6.  Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma.

Authors:  Neda Rezaee; Carlotta Barbon; Ahmed Zaki; Jin He; Bulent Salman; Ralph H Hruban; John L Cameron; Joseph M Herman; Nita Ahuja; Anne Marie Lennon; Matthew J Weiss; Laura D Wood; Christopher L Wolfgang
Journal:  HPB (Oxford)       Date:  2015-12-10       Impact factor: 3.647

Review 7.  Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: recommendations for Standardized Imaging and Reporting from the Society of Abdominal Radiology IPMN disease focused panel.

Authors:  Elizabeth M Hecht; Gaurav Khatri; Desiree Morgan; Stella Kang; Priya R Bhosale; Isaac R Francis; Namita S Gandhi; David M Hough; Chenchan Huang; Lyndon Luk; Alec Megibow; Justin M Ream; Dushyant Sahani; Vahid Yaghmai; Atif Zaheer; Ravi Kaza
Journal:  Abdom Radiol (NY)       Date:  2020-11-13

Review 8.  Pancreatic Cysts and Guidelines.

Authors:  James J Farrell
Journal:  Dig Dis Sci       Date:  2017-05-20       Impact factor: 3.199

9.  Accuracy of 2012 International Consensus Guidelines for the prediction of malignancy of branch-duct intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Enrique Pérez-Cuadrado Robles; Frédérique Maire; Jérôme Cros; Marie-Pierre Vullierme; Vinciane Rebours; Alain Sauvanet; Alain Aubert; Safi Dokmak; Philippe Lévy; Philippe Ruszniewski
Journal:  United European Gastroenterol J       Date:  2016-01-06       Impact factor: 4.623

Review 10.  Treatment of branch-duct intraductal papillary mucinous neoplasms of the pancreas: state of the art.

Authors:  Stefano Crippa; Alessandra Piccioli; Maria Chiara Salandini; Chiara Cova; Francesca Aleotti; Massimo Falconi
Journal:  Updates Surg       Date:  2016-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.